Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium
- PMID: 34433304
- PMCID: PMC8840795
- DOI: 10.1097/JU.0000000000002176
Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium
Abstract
Purpose: Our goal was to evaluate the comparative effectiveness of robot-assisted laparoscopic prostatectomy (RALP) and open radical prostatectomy (ORP) in a multicenter study.
Materials and methods: We evaluated men with localized prostate cancer at 11 high-volume academic medical centers in the United States from the PROST-QA (2003-2006) and the PROST-QA/RP2 cohorts (2010-2013) with a pre-specified goal of comparing RALP (549) and ORP (545). We measured longitudinal patient-reported health-related quality of life (HRQOL) at pre-treatment and at 2, 6, 12, and 24 months, and pathological and perioperative outcomes/complications.
Results: Demographics, cancer characteristics, and margin status were similar between surgical approaches. ORP subjects were more likely to undergo lymphadenectomy (89% vs 47%; p <0.01) and nerve sparing (94% vs 89%; p <0.01). RALP vs ORP subjects experienced less mean intraoperative blood loss (192 vs 805 mL; p <0.01), shorter mean hospital stay (1.6 vs 2.1 days; p <0.01), and fewer blood transfusions (1% vs 4%; p <0.01), wound infections (2% vs 4%; p=0.02), other infections (1% vs 4%; p <0.01), deep venous thromboses (0.5% vs 2%; p=0.04), and bladder neck contractures requiring dilation (1.6% vs 8.3%; p <0.01). RALP subjects reported less pain (p=0.04), less activity interference (p <0.01) and higher incision satisfaction (p <0.01). Surgical approach (RALP vs ORP) was not a significant predictor of longitudinal HRQOL change in any HRQOL domain.
Conclusions: In high-volume academic centers, RALP and ORP patients may expect similar long-term HRQOL outcomes. Overall, RALP patients have less pain, shorter hospital stays, and fewer post-surgical complications such as blood transfusions, infections, deep venous thromboses, and bladder neck contractures.
Trial registration: ClinicalTrials.gov NCT01325506.
Keywords: prostatectomy; quality of life; robotic surgical procedures.
Conflict of interest statement
Conflicts of Interest/Disclosures:
Peter Chang: none
Andrew Wagner: none
Meredith Regan: none
Joseph Smith: none
Christopher Saigal: none
Mark Litwin: none
Jim Hu: supported by “The Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust”, PCORI CER-2019C1–15682, PCORI CER-2019C2–17372, and NCI RO1 CA241758.
Matthew Cooperberg: none
Peter Carroll: none
Eric Klein: none
Adam Kibel consults for Dendreon and Sanofi.
Gerald Andriole: none
Misop Han: none
Alan Partin: none
David Wood: none
Catrina Crociani: none
Thomas Greenfield: none
Dattatraya Patil: none
Larry Hembroff: none
Kyle Davis: none
Linda Stork: none
Daniel Spratt: none
John Wei: none
Martin Sanda: none
Figures
References
-
- Leow JJ, Chang SL, Meyer CP, et al. Robot-assisted Versus Open Radical Prostatectomy: A Contemporary Analysis of an All-payer Discharge Database. Eur Urol 2016. Nov;70(5):837–845. Epub 2016 Feb 11. - PubMed
-
- Makarov DV, Li H, Lepor H, et al. Teaching Hospitals and the Disconnect Between Technology Adoption and Comparative Effectiveness Research: The Case of the Surgical Robot. Med Care Res Rev 2017. Jun;74(3):369–376. Epub 2016 Mar 30. - PubMed
-
- Barry MJ, Fowler FJ Jr, O’Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committeee of the American Urological Association. J Urol 1992; 148(5): 1549–57. - PubMed
-
- Hu JC, Gu X, Lipsitz SR, et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 2009. Oct 14;302(14):1557–64. - PubMed
